Stable expression of C/EBPα in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity

Prostate

Volumn 62, Issue 3, 2005, Pages 209-216

  Yin, Hong ^a   Smith, Mylinh ^a   Glass, Jonathan ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Gene expression; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; ISOPROTEIN; LUCIFERASE; METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN IA; METALLOTHIONEIN IB; METALLOTHIONEIN IF; METALLOTHIONEIN IH; METALLOTHIONEIN II; METALLOTHIONEIN III; RETROVIRUS VECTOR; RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL STRAIN PC3; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REPORTER GENE; STRESS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, NEOPLASM; HUMANS; MALE; METALLOTHIONEIN; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; UP-REGULATION; ZINC;

EID: 12344315827     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20136     Document Type: Article

References (49)

1. Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000;35:35-70.
2. Kagi JH, Kojima Y. Chemistry and biochemistry of metallothionein. Experientia Suppl 1987;52:25-61.
3. Andrews GK. Regulation of metallothionein gene expression. Prog Food Nutr Sci 1990;14:193-258.
4. Del Razo LM, Quintanilla-Vega B, Brambila-Colombres E, Calderon-Aranda ES, Manno M, Albores A. Stress proteins induced by arsenic. Toxicol Appl Pharmacol 2001;177:132-148.
5. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr Suppl 2003;133:60S-62S.
6. Coyle P, Philcox JC, Carey LC. Rofe AM. Metallothionein: The multipurpose protein. Cell Mol Life Sci 2002;59:627-647.
7. Choi CH. Cloning and functional study of a novel human metallothionein-I isoform induced by paraquat. Biochem Biophys Res Commun 2003;304:236-240.
8. Lichtlen P, Schaffner W. The "metal transcription factor" MTF-1: Biological facts and medical implications. Swiss Med Wkly 2001;131:647-652.
9. Lichtlen P, Wang Y, Belser T, Georgiev O, Certa U, Sack R, Schaffner W. Target gene search for the metal-responsive transcription factor MTF-1. Nucleic Acids Res 2001;29:1514-1523.
10. Andrews GK, Lee DK, Ravindra R, Lichtlen P, Sirito M, Sawadogo M, Schaffner W. The transcription factors MTF-1 and USF1 cooperate to regulate mouse metallothionein-I expression in response to the essential metal zinc in visceral endoderm cells during early development. EMBO J 2001;20:1114-1122.
11. Radtke F, Heuchel R, Georgiev O, Hergersberg M, Gariglio M, Dembic Z, Schaffner W. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J 1993;12:55-62.
12. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, Schaffner W. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J 1994;13:2870-2875.
13. Smirnova IV, Bittel DC, Ravindra R, Jiang H, Andrews GK. Zinc and cadmium can promote rapid nuclear translocation of metal response element-binding transcription factor-1. J Biol Chem 2000;275:9377-9384.
14. Chimienti F, Aouffen M, Favier A, Seve M. Zinc homeostasis-regulating proteins: New drug targets for triggering cell fate. Curr Drug Targets 2003;4:323-338.
15. McKenna IM, Bare RM, Waalkes MP. Metallothionein gene expression in testicular interstitial cells and liver of rats treated with cadmium. Toxicology 1996;107:121-130.
16. Klaassen CD, Liu J. Induction of metallothionein as an adaptive mechanism affecting the magnitude and progression of toxicological injury. Environ Health Perspect Suppl 1998;106:297-300.
17. Moffatt P, Plaa GL, Denizeau F. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N′-nitro-N- nitrosoguanidine cytotoxicity. Toxicol Appl Pharmacol 1996;136:200-207.
18. Morcillo MA, Rucandio MI, Santamaria J. Effect of gamma irradiation on liver metallothionein synthesis and lipid peroxidation in rats. Cell Mol Biol 2000;46:435-444.
19. Eneman JD, Potts RJ, Osier M, Shukla GS, Lee CH, Chiu JF, Hart BA. Suppressed oxidant-induced apoptosis in cadmium adapted alveolar epithelial cells and its potential involvement in cadmium carcinogenesis. Toxicology 2000;147:215-228.
20. Habeebu SS, Liu J, Liu Y, Klaassen CD. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium. Toxicol Sci 2000;55:223-232.
21. Liu J, Liu Y, Goyer RA, Achanzar W, Waalkes MP. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol Sci 2000;55:460-467.
22. Qu W, Diwan BA, Liu J, Goyer RA, Dawson T, Horton JL, Cherian MG, Waalkes MP. The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies. Am J Pathol 2002;160:1047-1056.
23. Kimura T, Itoh N, Takehara M, Oguro I, Ishizaki JI, Nakanishi T, Tanaka K. Sensitivity of metallothionein-null mice to LPS/D-galactosamine-induced lethality. Biochem Biophys Res Commun 2001;280:358-362.
24. Yao CP, Allen JW, Mutkus LA, Xu SB, Tan KH, Aschner M. Foreign metallothionein-I expression by transient transfection in MT-I and MT-II null astrocytes confers increased protection against acute methylmercury cytotoxicity. Brain Res 2000;855:32-38.
25. Suzuki T, Umeyama T, Ohma C, Yamanaka H, Suzuki K, Nakajima K, Kimura M. Immunohistochemical study of metallothionein in normal and benign prostatic hyperplasia of human prostate. Prostate 1991;19:35-42.
26. Zhang XH, Jin L, Sakamoto H, Takenaka I. Immunohistochemical localization of metallothionein in human prostate cancer. J Urol 1996;156:1679-1681.
27. Garrett SH, Sens MA, Shukla D, Flores L, Somji S, Todd JH, Sens DA. Metallothionein isoform 1 and 2 gene expression in the human prostate: Downregulation of MT-1X in advanced prostate cancer. Prostate 2000;43:125-135.
28. Moussa M, Kloth D, Peers G, Cherian MG, Frei JV, Chin JL. Metallothionein expression in prostatic carcinoma: Correlation with Gleason grade, pathologic stage, DNA content, and serum level of prostate-specific antigen. Clin Invest Med 1997;20:371-380.
29. Waalkes MP, Rehm S. Cadmium and prostate cancer. J Toxicol Environ Health 1994;43:251-269.
30. Jacob ST, Majumder S, Ghoshal K. Suppression of metallothionein-I/II expression and its probable molecular mechanisms. Environ Health Perspect Suppl 2002;110:827-830.
31. Garrett SH, Sens MA, Shukla D, Nestor S, Somji S, Todd JH, Sens DA. Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines. Prostate 1999;41:196-202.
32. Johnson PF, Landschulz WH, Graves BJ, McKnight SL. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1987;1:133-146.
33. Landschulz WH, Johnson PF, Adashi EY, Graves BJ, McKnight SL. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 1988;2:786-800.
34. Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 1988;240:1759-1764.
35. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ, Lane MD. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 1989;3:1323-1335.
36. Dixon TM, Daniel KW, Farmer SR, Collins S. CCAAT/enhancer-binding protein alpha is required for transcription of the beta 3-adrenergic receptor gene during adipogenesis. J Biol Chem 2001;276:722-728.
37. Yamanaka R, Lekstrom-Himes J, Barlow C, Wynshaw-Boris A, Xanthopoulos KG. CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis. Int J Mol Med 1998;1:213-221.
38. Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol 1998;18:322-333.
39. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. Dominant-negative mutations of C/EBPα, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001;27:263-270.
40. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 2002;62:528-534.
41. Mizzen CA, Cartel NJ, Yu WH, Fraser PE, McLachlan DR. Sensitive detection of metallothionems-1, -2 and -3 in tissue homogenates by immunoblotting: A method for enhanced membrane transfer and retention. J Biochem Biophys Methods 1996;32:77-83.
42. Ghoshal K, Majumder S, Zhu Q, Hunzeker J, Datta J, Shah M, Sheridan JF, Jacob ST. Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms. Mol Cell Biol 2001;21(24):8301-8317.
43. Ogra Y, Suzuki K, Gong P, Otsuka F, Koizumi S. Negative regulatory role of Sp1 in metal responsive element-mediated transcriptional activation. J Biol Chem 2001;276:16534-16539.
44. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998;35:285-296.
45. Costello LC, Franklin RB. The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000;59:269-282.
46. Gopalakrishna R, Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr 2002;132:3819S-3823S.
47. Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997;272:28875-28881.
48. Feng P, Li TL, Guan ZX, Franklin RB. Costello LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002;52:311-318.
49. Watkins PJ, Condreay JP, Huber BE, Jacobs SJ, Adams DJ. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res 1996;56:1063-1067.